Curaleaf’s financials disappoint as analysts cut forecasts and its balance sheet remains burdened by debt, making it an unattractive cannabis stock for… Curaleaf’s financials disappoint as analysts cut forecasts and its balance sheet remains burdened by debt, making it an unattractive cannabis stock for…  Read More  

By